Medical Economics August 23, 2024
In theory, patients should benefit from drug price discounts negotiated between drug companies and insurers. In reality, they don’t, and a potential solution is stalled in Congress.
A simple reform to Medicare’s prescription drug program could put billions of dollars back into seniors’ pockets over the next decade. That would help them better manage their chronic conditions and significantly lower overall health spending. Concerningly, that reform is gathering dust. That’s a huge problem for seniors – and one we need to fix sooner rather than later.
More than two-thirds of Medicare beneficiaries have multiple chronic illnesses. They face health care costs five times higher than their peers without any chronic conditions. And right now, because of the way Medicare is...
Today's Sponsors
Today's Sponsor